Inactive Instrument

SweeGen, Inc. Stock Other OTC

SWEE

US8703341094

SweeGen, Inc. is a development-stage company. The Company intends to leverage the experience of its new corporate and scientific management team, which has experience in managing and developing large and small private and public companies; pathway engineering; microbial platform development, and developing and manufacturing food ingredients, biological products, dietary supplements and botanical extracts. The Company focuses on seeking, developing and acquiring, completely or a substantial interest in, companies or assets. The Company's subsidiary is Phytosub, Inc. As of June 30, 2016, the Company had not generated any revenues.

Employees

Sector

Food Processing

More about the company

As early as today, start finding the best investment opportunities!

23-08-31	Sweegen's Rebaudioside M Sweetener Technology Receives Regulatory Approval in Taiwan	CI
22-12-05	Sweegen, Inc. Announces Growth Capital Investments and Manufacturing Partnership with Sumitomo Chemical Co	CI
22-12-04	SweeGen, Inc. announced that it has received funding from Sumitomo Chemical Company, Limited, Pasaca Capital, Inc.	CI
22-07-08	Conagen and Sweegen Teams Up to Develop Modern Natural Sweeteners	CI
22-04-05	Sweegen’s Signature Stevia Receives Approval in Colombia	CI
22-03-15	Sweegen Expands Signature Stevia Footprint in Mexico	CI
22-02-01	Sweegen Blazes New Territory in Sugar Reduction with Forward Progress in Brazzein	CI
21-10-04	Sweegen Expands Sugar Reduction Portfolio with High-Intensity Sweetener Brazzein	CI
21-09-16	Sweegen Announces Premiumization of Low-Calorie Confectionery Chocolate	CI
21-07-15	European Union Commission Publishes Approval of Sweegen’S Non-Gmo Signature Bestevia Rebaudioside M (Reb M) for Use in Food and Beverages	CI
21-05-04	The Malaysia Ministry of Health Accepts Sweegen?s Zero-Calorie Bestevia Sweeteners, Rebaudiosides D, E and M for Use as Ingredients in Food and Beverage Products	CI
21-04-14	SweeGen’s Bestevia Reb M Heads to Final Approval in European Union	CI
21-03-15	SweeGen’s Bestevia® Rebaudioside B Receives U.S. FDA GRAS No Objection Letter	CI

20-10-15	PTAB: Inadvertent Mistake In Analysis Of Experimental Data That Substantially Impacts Proceeding Cannot Be Corrected	AQ
20-04-02	Sumitomo Chemical : Invests in Conagen, U.S. Bio-Venture	AQ

Manager	Title	Age	Since
Steven Chen CEO	Chief Executive Officer	61	2014-12-22
Jeremy Klaperman DFI	Director of Finance/CFO	-	-
Michael Halvorsen PRN	Corporate Officer/Principal	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SWEEGEN, INC.	-4.55%	-.--%	-	-	15.37M
GUANGXI YUEGUI GUANGYE HOLDINGS CO., LTD.	-3.69%	-1.92%	+94.38%	+323.42%	2.78B
SÜDZUCKER AG	0.00%	+2.46%	-2.35%	-36.76%	2.54B
COSUMAR SA	+0.52%	+4.06%	-22.65%	-1.59%	1.97B
ILLOVO SUGAR (MALAWI) PLC	0.00%	+0.00%	+95.50%	+212.27%	1.44B
ADECOAGRO S.A.	+1.69%	+2.44%	+2.88%	-0.21%	1.39B
BALRAMPUR CHINI MILLS LIMITED	+1.59%	+8.41%	-5.20%	+48.89%	1.25B
ZAMBIA SUGAR PLC	0.00%	0.00%	+65.55%	+283.89%	1.19B
TRIVENI ENGINEERING & INDUSTRIES LIMITED	+1.86%	+13.32%	+25.79%	+65.67%	1.05B
SÃO MARTINHO S.A.	-0.58%	+3.19%	-13.05%	-54.06%	968M
Average	-0.32%	+3.37%	+26.76%	+93.50%	1.62B
Weighted average by Cap.	-0.24%	+2.86%	+30.14%	+104.51%

SweeGen, Inc. Stock Other OTC

Stocks

SWEE

US8703341094

Food Processing

Latest news : SweeGen, Inc.

Press Releases: SweeGen, Inc.

Quotes and Performance

Managers and Directors: SweeGen, Inc.

Sugar & Artificial Sweeteners

Company Profile